Drug Patents owned by Baxter Hlthcare

1. List of Nexterone drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6869939 BAXTER HLTHCARE Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
May, 2022

(8 months ago)

US7635773 BAXTER HLTHCARE Sulfoalkyl ether cyclodextrin compositions
Mar, 2029

(6 years from now)

Drugs and Companies using AMIODARONE HYDROCHLORIDE ingredient

Market Authorisation Date: 24 December, 2008

Treatment: NA

Dosage: INJECTABLE;INJECTION

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic